• 沒有找到結果。

一、結論

1. 本研究證實了 RSOM-31 確實為一簡便且有效評估慢性鼻竇 炎患者生活品質的工具,且中文版問卷之信度與英文版一樣 皆高於0.9 以上,因此建議可以作為慢性鼻竇炎治療介入的 療效評估工具,同時可作為醫療工作者之決策參考。另外,

RSOM-31 之使用相當簡便,回答時間亦很簡短,可於門診 間即可完成,因此可作為經常性的監測工具,一來可簡便評 估患者之治療成效,再者大量收集的資料亦能作為日後研究 的比較與參考。

2. 慢性鼻竇炎影響患者之生活品質確實是多方面的,尤以睡眠 及情緒上的影響最為嚴重。

3. 本研究收案之慢性鼻竇炎患者,其治療前鼻腔內之黴菌培養 率平均約為75.6%。

4. 本研究證實,在鼻沖洗液中加入 amphotericin B 沖洗鼻腔之 治療方法,確實為一安全且有效治療慢性鼻竇炎的方式,且 比單純使用生理食鹽水沖洗鼻腔,更能提升慢性鼻竇炎患者 之生活品質進步。

5. 不論實驗組或控制組,在沖洗治療一個月後,其臨床指標,

包括內視鏡疾病嚴重度及鼻腔內黴菌培養率,均無明顯變 化。

6. 由於本實驗只探討臨床療效部分,故從本研究結果並無法有 效推論或解釋黴菌在慢性鼻竇炎中之真正角色及致病機轉。

二、建議

1. 本研究雖然證實利用抗黴菌藥物 amphotericin B 沖洗鼻腔確 實為一安全且有效治療慢性鼻竇炎的方法,建議若其他治療 方式無效之慢性鼻竇炎患者,可嘗試利用amphotericin B 之 鼻沖洗液加以治療,但依目前本研究調配之治療濃度,其長 期累計之費用似乎過高,較不符成本效益,目前並不建議一 般慢性鼻竇炎患者常規使用。

2. 本研究證實,單純利用生理食鹽水沖洗鼻腔之方式(控制 組),不僅可作為治療慢性鼻竇炎之輔助療法,且單純使用 亦可增進患者之生活品質進步,對於不適合手術或不願接受 其他藥物治療的病患,可建議作為主要治療方式。

3. 雖然慢性鼻竇炎之真正致病機轉及黴菌的角色尚未完全釐 清,但由本實驗結果證實,抗黴菌藥物確實可有效治療病人

之症狀,建議臨床工作者及後續研究者可針對更基礎之分子 生物學及病理生理學,對慢性鼻竇炎及黴菌相關之致病機轉 加以深入研究,以早日釐清兩者之相關性。另外,亦可嘗試 不同濃度及途徑之抗黴菌藥物治療,以期達到臨床療效之餘

並能盡量減低治療成本。

參考文獻

一、英文文獻

Abbas, A.A., Felimban, S.K., Yousef A.A., Khattab T.M., Fryer C.J., Nandagopal N.

Aggressive cutaneous aspergillus infection: control by local irrigation with amphotericin B”Med Pediatr Oncol , Vol. 39, pp.139-40, 2002.

Anderson, ER., Murphy MP., Weymuller, EA Jr.“Clinimetric evaluation of the Sinonasal Outcome Test-16.”Student Research Award 1998. [Journal Article]

Otolaryngology - Head & Neck Surgery, Vol. 121, No. 6, pp.702-7, 1999 Dec.

Anon, J. (ed),“Report of the Task Force on Rhinosinusitis.”, Otolaryngol Head Neck Surg, Vol. 117(Suppl), pp.S1-68,1997.

Benninger MS, Ferguson BJ, Hadley JA, et al. Adult chronic rhinosinusitis:

definitions, diagnosis, epidemiology, and pathophysiology. Otolaryngol Head Neck Surg 2003;129:S1-32.

Benninger MS. Senior BA. The development of the Rhinosinusitis Disability Index.

[Journal Article] Archives of Otolaryngology -- Head & Neck Surgery.

123(11):1175-9, 1997 Nov.

Birch DS, Saleh HA, Wodehouse T, et al. Assessing the quality of life for patients with chronic rhinosinusitis using the ‘Rhinosinusitis Disability Index’. Rhinology 2001; 39:191-196

Bowling A. Measuring disease : A review of quality measurement scale. Philadelphia:

Open University Press ; 1995.p.1-6.

Collins JG: Prevalence of selected chronic conditions, United States, 1983-85, National Center for Health Statistics Advance Data 1988; 155:1-16.

Damm M. Quante G. Jungehuelsing M. Stennert E. Impact of functional endoscopic sinus surgery on symptoms and quality of life in chronic rhinosinusitis. [Journal Article] Laryngoscope. 112(2):310-5, 2002 Feb.

Drew RH, Arthur RR, Perfect JR. Is it time to abandon the use of amphotericin B bladder irrigation? Clin Infect Dis 2005;40:1465-70.

Durr DG. Desrosiers MY. Dassa C. Quality of life in patients with rhinosinusitis.

[Review] [33 refs] [Journal Article. Review. Review, Tutorial] Journal of Otolaryngology. 28(2):108-11, 1999 Apr.

Fahmy FF. McCombe A. Mckiernan DC. Sino nasal assessment questionnaire, a patient focused, rhinosinusitis specific outcome measure. [Journal Article. Validation Studies] Rhinology. 40(4):195-7, 2002 Dec

Gordts F, Clement PAR, Destrker A, Desprechins B, Kaufman L: Prevalence of sinusitis signs on MRI in a non-ENT pediatric population. Rhinology 1997;

35:154-157.

Instruments for clinical health-care research London: Jones and Bartlett publisher;

1997.p.114-34.

Jiang R. Mycology of chrnoic sinusitis. Proceedings of the 78th Annual Meeting of the Otorhinolaryngology Society of the ROC. Ga-Yi, Taiwan, 2005:30.

Juniper EF, Guyatt GH. Development and testing of a new measure of health status for clinical trials in rhinoconjunctivitis. Clin Exp Allergy 1991; 21:77-83.

Juniper EF, Thompson AK, Ferrie PJ, Roberts JN. Validation of the standardized version of the Rhinoconjunctivitis Quality of Life Questionnaire. J Allergy Clin Immunol 1999; 104:364-369.

Juniper EF, Thompson AK, Ferrie PJ, Roberts JN. Development and validation of the mini Rhinoconjunctivitis Quality of Life Questionnaire. Clin Exp Allergy 2000;

30:132-140.

Kaliner MA. Sinusitis: bench to bedside. Otolaryngol Head Neck Surg 1997;

166:S1-20.

Khalid AN. Quraishi SA. Kennedy DW. Long-term quality of life measures after functional endoscopic sinus surgery. [Clinical Trial. Journal Article. Randomized Controlled Trial] American Journal of Rhinology. 18(3):131-6, 2004 May-Jun.

Krouse JH: Introduction to sinus disease: I. Anatomy and physiology. ORL - Head &

Neck Nursing 1999; 17:7-12.

Liang K, Jiang R. The imfluence of pulsatile nasal irrigation on the prognosis of functional endoscopic sinus surgery. Proceedings of the 77th Annual Meeting of the

Otorhinolaryngology Society of the ROC. Taipei, Taiwan, 2004:68.

Meeberg GM. Quality of life: A concept analysis. J Adv Nurs

1993;18:32-8.Nelson HS. Advances in upper airway diseases and allergen immunotherapy. J Allergy Clin Immunol 2005;115:676-84.

Min YG, Jung HW, Kim HS, Park SK, Yoo KY: Prevalence and risk factors of chronic sinusitis in Korea: results of a nationwide survey. Eur Arch Otorhinolaryngol 1996;

253:435-439.

Padilla GV, Frank-Stormborg M. Single instruments for measuring quality of life. In:

Frank-Stormborg M, Olsen SJ, editors.

Ponikau JU, Sherris DA, Kern EB, et al. The diagnosis and incidence of allergic fungal sinusitis. Mayo Clin Proc 1999;74:877-84.

Ponikau JU, Sherris DA, Kita H, Kern EB. Intranasal antifungal treatment in 51 patients with chronic rhinosinusitis. J Allergy Clin Immunol 2002;110:862-6.

Ponikau JU, Sherris DA, Weaver A, Kita H. Treatment of chronic rhinosinusitis with intranasal amphotericin B: a randomized, placebo-controlled, double-blind pilot trial.

J Allergy Clin Immunol 2005;115:125-31.

Piccirillo JF, Merritt MG, Jr., Richards ML. Psychometric and clinimetric validity of the 20-Item Sino-Nasal Outcome Test (SNOT-20). Otolaryngol Head Neck Surg 2002;126:41-7.

Piccirillo JF, Edwards D, Haiduk A, Yonan C, Thawley SE. Psychometric and clinimetric validity of the 31-Item Rhinosinusitis Outcome Measure (RSOM-31).

Am J Rhinol. 1995;9:297-306

Revicki DA, Leidy NK, Brennan-Diemer F, et al. Development and preliminary validation of the multiattribute Rhinitis Symptom Utility Index. Qual Life Res 1998;

7:693-702.

Ricchetti A, Landis BN, Maffioli A, Giger R, Zeng C, Lacroix JS. Effect of anti-fungal nasal lavage with amphotericin B on nasal polyposis. J Laryngol Otol 2002;116:261-3.

Santilli J, Nathan R, Glassheim J, et al. Validation of the rhinitis outcomes

questionnaire (ROQ). Ann Allergy Asthma Immunol 2001; 86:222-225.

Sasama J, Sherris DA, Shin SH, Kephart GM, Kern EB, Ponikau JU. New paradigm for the roles of fungi and eosinophils in chronic rhinosinusitis. Curr Opin Otolaryngol Head Neck Surg 2005;13:2-8.

Schrage NF, Kompa S, Haller W, Langefeld S. Use of an amphoteric lavage solution for emergency treatment of eye burns. First animal type experimental clinical considerations. Burns 2002;28:782-6.

Senior BA. Glaze C. Benninger MS. Use of the Rhinosinusitis Disability Index (RSDI) in rhinologic disease. [Journal Article. Validation Studies] American Journal of Rhinology. 15(1):15-20, 2001 Jan-Feb.

Shilbuya TY, Momin F, Abella E: Sinus disease in the bone marrow transplant population: incidence, risk factors and complications. Otolaryngol Head Neck Surg 1995; 113: 705-711.

Shin SH, Ponikau JU, Sherris DA, et al. Chronic rhinosinusitis: an enhanced immune response to ubiquitous airborne fungi. J Allergy Clin Immunol 2004;114:1369-75.

Smith TL. Rhee JS. Loehrl TA. Burzynski ML. Laud PW. Nattinger AB. Objective testing and quality-of-life evaluation in surgical candidates with chronic rhinosinusitis. [Journal Article] American Journal of Rhinology. 17(6):351-6, 2003 Smith TL. Outcomes research in rhinology: chronic rhinosinusitis. [Journal Article]

Orl; Journal of Oto-Rhino-Laryngology & its Related Specialties. 66(4):202-6, 2004 Jul-Aug.

Taylor MJ, Ponikau JU, Sherris DA, et al. Detection of fungal organisms in eosinophilic mucin using a fluorescein-labeled chitin-specific binding protein.

Otolaryngol Head Neck Surg 2002;127:377-83.

The WHOQOL Group. The World Health Organization Quality oflife assessment

WHOQOL ) : Development and general psychometric properties. Soc Sci Med1998;46:1569-85.

Van Cauwenberge P, Watelet JB: Epidemiology of chronic rhinosinusitis. Thorax 2000; Suppl 2:S20-21

Wang PC. Tai CJ. Chu CC. Liang SC. Translation and validation assessment of the Chinese version of the chronic sinusitis survey. [Journal Article] Chang Gung Medical Journal. 25(1):9-15, 2002 Jan.

Wang PC. Tai CJ. Lin MS. Chu CC. Liang SC. Quality of life in Taiwanese adults with chronic rhino-sinusitis. [Journal Article] Quality of Life Research. 12(4):443-8, 2003 Jun.

Weschta M, Rimek D, Formanek M, Polzehl D, Podbielski A, Riechelmann H.

Topical antifungal treatment of chronic rhinosinusitis with nasal polyps: a randomized, double-blind clinical trial. J Allergy Clin Immunol 2004;113:1122-8.

Wilson IB, Cleary PD. Linking clinical variables with health-related quality of life.

JAMA1995;273:59-65.

二、中文文獻

楊偉杰;郝治華;廖兆旺,”慢性鼻竇炎患者之鼻鼻竇腔解剖變異”,中華民國耳鼻 喉科醫學雜誌,第 36 卷,第 3 期,第 165-171 頁,民 90 年。

葉德輝,”小兒鼻竇炎治療新趨勢”,健康世界,第 129 卷,第 249 期,第 27-29 頁,民 85 年。

謝嘉成;呂克桓,”過敏性鼻炎和鼻竇炎之關係”, 台灣兒童過敏氣喘及免疫學 會學會通訊,第 2 卷,第 4 期,第 15-16 頁,民 90 年。

劉博仁 李采娟,”過敏性鼻炎患者接受免疫療法之生活品質”,台灣醫學,第 9 卷,第 4 期,第 455-466 頁,民 94 年。

盧令儀,”某教學醫院冠狀動脈疾病病患施行心臟相關手術術後生活品質之探 討”,長庚大學管理研究所醫務管理組碩士論文,民國 89 年。

蕭聖謀 李憲彥,”鼻竇炎的診斷與治療”,當代醫學,第 22 卷,第 3 期,第 189-191 頁,民 84 年。

戴志展等,”鼻竇內視鏡手術患者對療程之滿意度分析”, 中華民國耳鼻喉科醫 學雜誌,第 37 卷,第 1 期,第 15-21 頁,民 91 年。

附錄一 英文版 RSOM-31

ID:

RHINOSINUSITIS OUTCOME MEASURE PRE-TREATMENT

Below you will find a list of symptoms, functional limitations, and emotional consequences of your rhinosinusitis. We would like to know more about these problems and would appreciate your answering the following questions to the best of your ability. There are no “right” or “wrong” answers, and only you can provide us with this information. Please rate your problems as they have been over the past two weeks. Thank you for your participation. Do not hesitate to ask our research assistant or other office staff members for assistance if necessary.

Listed after the symptoms, functional limitations, and emotional consequences are two columns labeled Magnitude and Importance. Please refer to the following instructions and scales provided below to answer these questions.

Magnitude Scale Importance Scale

Sleep

25. Inconvenience of having to

Carry tissues/ handkerchief... ...0 1 2 3 4 5 ...1 2 3 4 26. Need to rub nose/eyes... ...0 1 2 3 4 5 ...1 2 3 4 27. Need to blow your nose

Repeatedly... ...0 1 2 3 4 5 ...1 2 3 4 28. Bad breath... ...0 1 2 3 4 5 ...1 2 3 4 Emotional Consequences

29. Frustrated, impatient, restless

Or irritable... ...0 1 2 3 4 5 ...1 2 3 4 30. Feeling depressed or sad... ...0 1 2 3 4 5 ...1 2 3 4 31. Embarrassed by your symptoms... ...0 1 2 3 4 5 ...1 2 3 4

Please feel free to add any additional comments below. Thank you for you participation.

ADDITIONAL COMMENTS:

附錄二 中文版 RSOM-31

11.眼睛腫脹、痠痛 0 1 2 3 4 5 1 2 3 4

作者簡傳

姓名:林 子 凱 性 別:男

生日:1972 年 01 月 11 日

學歷:中國醫藥大學醫務管理研究所碩士班(2004~2006 )

中國醫藥大學醫學系畢業(1990-1997)

現職:嘉義榮民醫院耳鼻喉科主任 2005.10-迄今

嘉義榮民醫院耳鼻喉科主治醫師 2004.07-迄今

經歷:台大醫院實習醫師 1996.07-1997.06

海軍總部督察長室少尉軍醫官 1997.10-1999.06

台中榮民總醫院耳鼻喉部住院醫師及總醫師 1999.07-2003.06

台中榮民總醫院耳鼻喉部臨床研究員 2003.07-2004.06

國防大學國防醫學院臨床講師 2000.07-2005.07

參與學會:台灣醫學會

中華民國耳鼻喉科醫學會

台灣顏面整形重建外科醫學會

相關文件